The CMS Conditions of Participation and Interpretive Guidelines

Bookmark and Share

The CMS Conditions of Participation and Interpretive Guidelines

Product Code: CMSHCPIG8

Availability: In stock

Your Price:
Add Items to Cart

The CMS Conditions of Participation and Interpretive Guidelines

Compliance with the Conditions of Participation (CoP) is required to meet Medicare and Medicaid hospital regulations. While CMS posts updates to the CoPs on its website, they are often difficult to search and lengthy, not to mention tedious to print.

This is where HCPro comes in! We have taken the most recent version of CMS’ CoPs and the corresponding Interpretive Guidelines (IG) and reprinted them in an easy-to-use format to simplify your job. CMS updates the CoPs a few times a year. This new edition contains the most recent CoPs and Survey and Certification memos, which include new requirements on Immediate Jeopardy, ligature risk, and emerging infectious diseases.

This resource:

  • Includes CMS survey protocol
  • Provides the most recent EMTALA IGs
  • Offers the latest CoP IGs from CMS
  • Acts as an easy-to-read hard-copy reference of CoPs and IGs, which are otherwise cumbersome to reference online

Published: September 2019

Pages: 574
Dimensions: 8.5” X 11”
ISBN: 978-1-68308-969-8

Table of Contents


  • What to Look For in 2019: Ligature Risk, Infection Control, Drug Safety, and More CMS Pressure on AOs
  • Dialysis Tips
  • Joint Commission and CIHQ Respond to CMS Conflict-of-Interest Concerns
  • Ebola, Zika, and the Flu: CMS and CDC Want Action on Emerging Infections
  • CMS Revises Immediate Jeopardy Process
  • Review Hospital Policies After Suicide Risk NPSG Clarified in Updated FAQs
  • New Compounding Pharmacy Certification Designed to Boost Compliance
  • How to Track Updates

Appendix A

  • Appendix A Survey Protocol
  • Appendix A Regulations and Interpretive Guidelines

Available as a download:

  • CMS Memos
  • Appendix V (EMTALA)
    • Appendix V Part I: Investigative Procedures
  • Appendix V Part II: Interpretive Guidelines